BackOdonate Therapeutics Overview

Odonate Therapeutics Current Assets

Track Odonate Therapeutics's current assets ($100M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$99.58M
47.79% YoYΔ $-91.14M vs prior year quarter

Peer trimmed avg / median

Loading

Odonate Therapeutics Current Assets History

Loading

Odonate Therapeutics vs. peers: Current Assets Comparison

Loading

Odonate Therapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Odonate Therapeutics (ODT) FAQ

As of the most recent data (September 2021), ODT shows a current assets of $100M. That compares with $190M in the prior-year period — down 47.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ODT's current assets is now $100M (was $190M) — a 47.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Odonate Therapeutics is outperforming or lagging.

Tracking ODT's current assets over time shows whether Odonate Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $100M That compares with $190M in the prior-year period — down 47.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Odonate Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $100M) with ownership activity and broader fundamentals.

Odonate Therapeutics's current assets is $100M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.